Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
Top Cited Papers
Open Access
- 23 March 2014
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 44 (1), 23-63
- https://doi.org/10.1183/09031936.00188313
Abstract
The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) substantially challenges TB control, especially in the European Region of the World Health Organization, where the highest prevalence of MDR/XDR cases is reported. The current management of patients with MDR/XDR-TB is extremely complex for medical, social and public health systems. The treatment with currently available anti-TB therapies to achieve relapse-free cure is long and undermined by a high frequency of adverse drug events, suboptimal treatment adherence, high costs and low treatment success rates. Availability of optimal management for patients with MDR/XDR-TB is limited even in the European Region. In the absence of a preventive vaccine, more effective diagnostic tools and novel therapeutic interventions the control of MDR/XDR-TB will be extremely difficult. Despite recent scientific advances in MDR/XDR-TB care, decisions for the management of patients with MDR/XDR-TB and their contacts often rely on expert opinions, rather than on clinical evidence. This document summarises the current knowledge on the prevention, diagnosis and treatment of adults and children with MDR/XDR-TB and their contacts, and provides expert consensus recommendations on questions where scientific evidence is still lacking.Keywords
This publication has 225 references indexed in Scilit:
- Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infectionEmerging Infectious Diseases, 2013
- Xpert (R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults (Review)Published by Wiley ,2012
- National Survey of Drug-Resistant Tuberculosis in ChinaThe New England Journal of Medicine, 2012
- Material incentives and enablers in the management of tuberculosisPublished by Wiley ,2012
- Integration of Antiretroviral Therapy with Tuberculosis TreatmentThe New England Journal of Medicine, 2011
- Timing of Antiretroviral Therapy for HIV-1 Infection and TuberculosisThe New England Journal of Medicine, 2011
- Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation studyThe Lancet, 2011
- Rapid Molecular Detection of Tuberculosis and Rifampin ResistanceThe New England Journal of Medicine, 2010
- Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysisThe Lancet Infectious Diseases, 2009
- Transmission of tubercle bacilli: The effects of chemotherapyTubercle, 1976